On 2025-05-14, Quantum Biopharma Ltd. (V.QNT) announced earnings per share of -2.02 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of -0.50.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of -0.51 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | -0.50 | -2.02 |
| 2025-03-28 | 2024-12-31 | -1.08 | -4.04 |
| 2024-11-11 | 2024-09-30 | -- | -5.96 |
| 2024-08-14 | 2024-06-30 | -5.19 | -7.14 |
| 2024-05-14 | 2024-03-31 | -4.55 | -4.55 |
| 2024-03-28 | 2023-12-31 | -- | -3.25 |
| 2023-11-14 | 2023-09-30 | -- | -2.60 |
| 2023-07-20 | 2023-06-30 | -- | -12.34 |
| 2023-05-12 | 2023-03-31 | -- | -22.73 |
| 2023-03-31 | 2022-12-31 | -- | -14.29 |
| 2022-11-11 | 2022-09-30 | -- | -16.23 |
| 2022-08-12 | 2022-06-30 | -- | -17.53 |
| 2022-05-13 | 2022-03-31 | -- | -11.69 |
| 2022-03-31 | 2021-12-31 | -- | -12.34 |
| 2021-11-12 | 2021-09-30 | -- | -12.34 |
| 2021-08-12 | 2021-06-30 | -- | -27.92 |
| 2021-05-07 | 2021-03-31 | -- | -28.57 |
| 2021-03-16 | 2020-12-31 | -- | -18.83 |
| 2020-11-12 | 2020-09-30 | -46.75 | -61.69 |
| 2020-08-07 | 2020-06-30 | -72.08 | -46.10 |
| 2020-05-15 | 2020-03-31 | -- | -99.35 |
| 2020-03-03 | 2019-12-31 | -- | -87.01 |
| 2019-11-29 | 2019-09-30 | -92.86 | -110.39 |
| 2019-08-29 | 2019-06-30 | -- | -129.87 |
| 2019-05-30 | 2019-03-31 | -- | 0.00 |